TY  - JOUR
AU  - Panagiota, Victoria
AU  - Kerschbaum, Johanna Franziska
AU  - Penack, Olaf
AU  - Stein, Catarina M
AU  - Arends, Christopher M
AU  - Koenecke, Christian
AU  - Strzelecka, Paulina M
AU  - Kloos, Arnold
AU  - Wiegand, Laura
AU  - Lasch, Alina
AU  - Altwasser, Robert
AU  - Halik, Adriane
AU  - Gabdoulline, Razif
AU  - Thomson, Julia
AU  - Weibl, Konstantin
AU  - Franke, Georg-Nikolaus
AU  - Berger, Carolina
AU  - Hasenkamp, Justin
AU  - Ayuk, Francis
AU  - Na, Il-Kang
AU  - Beutel, Gernot
AU  - Keller, Ulrich
AU  - Bullinger, Lars
AU  - Wulf, Gerald Georg
AU  - Kröger, Nicolaus
AU  - Vucinic, Vladan
AU  - Heuser, Michael
AU  - Damm, Frederik
TI  - Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients.
JO  - HemaSphere
VL  - 7
IS  - 10
SN  - 2572-9241
CY  - [Philadelphia, Pennsylvania]
PB  - Wolters Kluwer Health
M1  - DKFZ-2023-02022
SP  - e957
PY  - 2023
AB  - Recent evidence revealed important interactions between clonal hematopoiesis (CH) and cellular therapies established for the treatment of hematologic malignancies. The impact of CH on safety, efficacy, and outcome of chimeric antigen receptor (CAR) T-cell therapy is currently under investigation. We analyzed 110 patients with relapsed/refractory B-cell non-Hodgkin lymphoma (n = 105) or acute lymphoblastic leukemia (ALL) (n = 5), treated with Axicabtagene-Ciloleucel (39
LB  - PUB:(DE-HGF)16
C6  - pmid:37799345
C2  - pmc:PMC10550045
DO  - DOI:10.1097/HS9.0000000000000957
UR  - https://inrepo02.dkfz.de/record/284602
ER  -